Claro Advisors LLC Abbott Laboratories Transaction History

Claro Advisors LLC

$706 Million
Q3 2024

A detailed history of Claro Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Claro Advisors LLC holds 9,125 shares of ABT stock, worth $1.03 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

9,125

Previous 2,500 265.0%

Holding current value

$1.03 Million

Previous $285,000 264.91%

% of portfolio

0.15%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$100.07 - $118.13 $913,138 - $1.08 Million	9,125 New	9,125 $1.04 Million
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $41,903 - $46,775	-416 Reduced 4.87%	8,128 $844,000
Q1 2024 Apr 18, 2024	BUY	$109.52 - $120.96 $32,527 - $35,925	297 Added 3.6%	8,544 $971,000
Q4 2023 Jan 22, 2024	BUY	$90.19 - $110.4 $68,995 - $84,456	765 Added 10.22%	8,247 $907,000
Q3 2023 Oct 10, 2023	BUY	$95.53 - $114.62 $297,480 - $356,926	3,114 Added 71.29%	7,482 $724,000
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $111,865 - $124,641	-1,110 Reduced 20.26%	4,368 $476,000
Q1 2023 Apr 17, 2023	BUY	$96.86 - $114.01 $10,267 - $12,085	106 Added 1.97%	5,478 $554,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $133,939 - $157,131	1,409 Added 35.55%	5,372 $589,000
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $81,145 - $98,079	795 Added 25.09%	3,963 $431,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $21,257 - $26,028	184 Added 6.17%	3,168 $446,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $15,165 - $16,777	130 Added 4.56%	2,984 $353,000
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $1,798 - $2,117	17 Added 0.6%	2,854 $331,000
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $9,795 - $11,540	-90 Reduced 3.07%	2,837 $340,000
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $73,500 - $80,094	-700 Reduced 19.3%	2,927 $321,000
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $19,610 - $23,816	-214 Reduced 5.57%	3,627 $395,000
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $8,422 - $10,780	110 Added 2.95%	3,841 $351,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $12,187 - $17,820	-194 Reduced 4.94%	3,731 $294,000
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $7,851 - $8,740	-100 Reduced 2.48%	3,925 $341,000
Q3 2019 Oct 29, 2019	BUY	$81.84 - $88.74 $31,672 - $34,342	387 Added 10.64%	4,025 $337,000
Q2 2019 Jul 24, 2019	BUY	$72.88 - $85.0 $3,935 - $4,590	54 Added 1.51%	3,638 $306,000
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $5,430 - $6,564	-82 Reduced 2.24%	3,584 $287,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $240,342 - $272,273	3,666 New	3,666 $269,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.

Account

Claro Advisors LLC Abbott Laboratories Transaction History